The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Joint Offers for Subscription

8 Jul 2022 15:28

RNS Number : 9000R
Maven Income & Growth VCT PLC
08 July 2022
 

Not for release, publication or distribution in whole or in part, in or into the United States, Canada, Australia, Japan, the Republic of South Africa or any jurisdiction for which the same could be unlawful. The information contained herein does not constitute an offer of securities for sale in any jurisdiction, including in the United States, Canada, Australia, Japan or the Republic of South Africa.

 

Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC

(the "Companies")

 

Statement re Intended Joint Offers for Subscription

 

The directors of the Companies are pleased to announce the intention to raise up to £30 million, in aggregate, by way of joint offers for subscription of new ordinary shares, with over-allotment facilities of up to, in aggregate, a further £10 million (the "Offers"), with shares to be issued in the 2022/23 and 2023/24 tax years.

Having considered the current cash reserves of the Companies and the amount intended to be raised under the Offers, the Boards are confident that, given the strength of the current pipeline of investment opportunities, the Companies' investment manager, Maven Capital Partners UK LLP, will continue to be able to identify and complete VCT qualifying transactions in line with each Company's investment strategy.

A prospectus, with full details of the Offers, is intended for publication in the Autumn of 2022. A further announcement will be made when the prospectus is available.

Applicants will be able to invest in any or all of the Offers, in accordance with the terms to be set out in the prospectus and subject to the relevant Offer(s) selected remaining open.

It is anticipated that the Offers will remain open until no later than 4 April 2023 in respect of the 2022/23 tax year and until 26 May 2023 in respect of the 2023/24 tax year, unless an Offer is fully subscribed at an earlier date and subject to each Board's right to close or extend the relevant Offer at any time.

 

On behalf of the Boards

Maven Capital Partners UK LLP

Secretary

8 July 2022

 

Notes

 

1. The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

2. This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBKFBBQBKDOOK
Date   Source Headline
5th Nov 20144:20 pmRNSTransaction in Own Shares
4th Nov 201411:46 amRNSTransaction in Own Shares
3rd Nov 20143:59 pmRNSTransaction in Own Shares
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
9th Oct 201412:30 pmRNSInterim Management Statement
3rd Oct 20144:27 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
21st Aug 20141:09 pmRNSTransaction in Own Shares
14th Aug 20145:07 pmRNSTransaction in Own Shares
13th Aug 201412:27 pmRNSTransaction in Own Shares
12th Aug 20142:38 pmRNSTransaction in Own Shares
11th Aug 20144:08 pmRNSTransaction in Own Shares
5th Aug 201411:36 amRNSReplacement Director/PDMR Shareholding
1st Aug 20143:23 pmRNSDirector/PDMR Shareholding
1st Aug 20143:20 pmRNSDirector/PDMR Shareholding
1st Aug 20143:19 pmRNSDirector/PDMR Shareholding
30th Jul 201411:12 amRNSHalf Yearly Report
4th Jul 20144:34 pmRNSReplacement re Issue of Equity
3rd Jul 20144:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20149:51 amRNSIssue of Equity
28th May 20145:13 pmRNSOffer for Subscription Update
27th May 201410:35 amRNSDirector Declaration
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:52 pmRNSOffer for Subscription - Supplementary Prospectus
22nd Apr 20143:00 pmRNSResult of AGM
22nd Apr 20142:58 pmRNSDirectorate Change
17th Apr 20143:57 pmRNSInterim Management Statement
16th Apr 201411:49 amRNSDirector Declaration
7th Apr 20144:19 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:32 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
3rd Mar 20144:13 pmRNSAnnual Financial Report
13th Feb 201410:57 amRNSDirector/PDMR Shareholding
13th Feb 201410:55 amRNSDirector/PDMR Shareholding
13th Feb 201410:47 amRNSDirector/PDMR Shareholding
10th Feb 20146:04 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:22 pmRNSIssue of Equity
3rd Feb 20145:23 pmRNSStatement re NAV and Offer for Subscription (Repla
27th Jan 20145:00 pmRNSStatement re NAV, Dividend and Offer
27th Nov 20132:07 pmRNSResult of General Meeting
24th Oct 20136:09 pmRNSOffer for Subscription
15th Oct 20135:10 pmRNSTransaction in Own Shares
11th Oct 20135:12 pmRNSInterim Management Statement
11th Oct 201312:18 pmRNSDirectorate Change
10th Oct 201311:02 amRNSNet Asset Value(s)
9th Oct 201311:09 amRNSNet Asset Value(s)
8th Oct 20131:49 pmRNSNet Asset Value(s)
7th Oct 201312:35 pmRNSNet Asset Value(s)
4th Oct 20132:12 pmRNSNet Asset Value(s)
3rd Oct 20132:36 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.